Morpholine → 5-Methyl-2-[2-(1-methyl-1H-benzoimidazol-2-yl)-ethyl]-7-morpholin-4-yl-3,5-dihydro-2H-pyrrolo[3,4-c]pyridine-1,6-dione
Reaction equation
CC1(C)C2C(=C(P(C3C=CC=CC=3)C3C=CC=CC=3)C=CC=2)OC2C(P(C3C=CC=CC=3)C3C=CC=CC=3)=CC=CC1=2.C([O-])([O-])=O.[Cs+].[Cs+].Cl[C:50]1[C:55](=[O:56])[N:54]([CH3:57])[CH:53]=[C:52]2[CH2:58][N:59]([CH2:62][CH2:63][C:64]3[N:68]([CH3:69])[C:67]4[CH:70]=[CH:71][CH:72]=[CH:73][C:66]=4[N:65]=3)[C:60](=[O:61])[C:51]=12.[NH:74]1[CH2:79][CH2:78][O:77][CH2:76][CH2:75]1>O1CCOCC1.C([O-])(=O)C.C([O-])(=O)C.[Pd+2]>[CH3:57][N:54]1[C:55](=[O:56])[C:50]([N:74]2[CH2:79][CH2:78][O:77][CH2:76][CH2:75]2)=[C:51]2[C:60](=[O:61])[N:59]([CH2:62][CH2:63][C:64]3[N:68]([CH3:69])[C:67]4[CH:70]=[CH:71][CH:72]=[CH:73][C:66]=4[N:65]=3)[CH2:58][C:52]2=[CH:53]1Participants
7
Reactant 4
Product 1
Reagents, catalysts & solvents 2
Conditions
- Temperature
- 120 °C
Procedure
Palladium diacetate (189 mg, 0.841 mmol), Xantphos (486 mg, 0.841 mmol) and Cs2CO3 (822 mg, 2.52 mmol) were each rapidly added in sequence to a suspension of 7-chloro-5-methyl-2-[2-(1-methyl-1H-benzoimidazol-2-yl)-ethyl]-3,5-dihydro-2H-pyrrolo[3,4-c]pyridine-1,6-dione (300 mg, 0.841 mmol, see Example c8)) and morpholine (220 mg, 2.52 mmol) in dioxane (1 ml). The reaction was heated in a microwave at about 120° C. for about 40 min. The solvent was removed and the resulting mixture was purified by preparative HPLC (system: Waters 2767 PHW003, eluent: MeCN/ammonium acetate buffer (gradient: 10:90 to 35:65 over 15 min), column: Boston Analytics, C-18, 10 μm, 21×250 mm) to afford the title compound (30 mg, 0.074 mmol, 8.76% yield)
Workup
- customThe solvent was removed
- customthe resulting mixture was purified by preparative HPLC (system: Waters 2767 PHW003, eluent: MeCN/ammonium acetate buffer (gradient: 10:90 to 35:65 over 15 min), column: Boston Analytics, C-18, 10 μm, 21×250 mm)
Sources & evidence
- ORD record
- ord-b2ee1e073a054567bf55774cc7c20fae
- Source dataset
- uspto-grants-2015_10
- Patent number
- US09163019B2
Reaction notes
Loading…